← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Benitec Biopharma BNTC $289M	21	0	0%	$1.55M
102	102 Genprex GNPX $1.91M	21	0	0%	$6.15M
103	103 DELISTED Orgenesis Inc. Common Stock ORGS	21	-1	-5%	$3.88M
104	FRLN 104 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	17	-2	-11%	$33.2M
105	KRBP 105 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	17	-3	-15%	$200K
106	SCPS 106 DELISTED Scopus BioPharma Inc. Common Stock SCPS	17	-2	-11%	$293K
107	107 IN8bio INAB $11.8M	15	+1	+7%	$5.5M
108	108 Creative Medical Technology CELZ $5.86M	14	0	0%	$1.13M
109	LGVN 109 Longeveron LGVN $5.52M	13	0	0%	$2.24M
110	110 BioRestorative Therapies BRTX $2.07M	12	0	0%	$976K
111	111 MiNK Therapeutics INKT $52.8M	11	-14	-56%	$504K
112	CYAD 112 DELISTED Celyad Oncology SA American Depositary Shares CYAD	8	0	0%	$11.4M
113	113 Immix Biopharma IMMX $706M	7	-1	-13%	$475K
114	114 NewcelX Ltd NCEL $15.1M	4	-1	-20%	$743K
115	115 Genenta Science GNTA $31.8M	3	0	0%	$27K
116	TCBP 116 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	3	+2	+200%	$166K
117	117 Artiva Biotherapeutics ARTV $289M	–	–	–	–
118	118 Coya Therapeutics COYA $98.1M	–	–	–	–
119	119 DELISTED CARGO Therapeutics CRGX	–	–	–	–
120	120 enGene Therapeutics ENGN $105M	–	–	–	–
121	121 FibroBiologics FBLG $6.73M	–	–	–	–
122	122 CytoMed Therapeutics GDTC $10.3M	–	–	–	–
123	123 Fractyl Health GUTS $54.1M	–	–	–	–
124	124 Kyverna Therapeutics KYTX $351M	–	–	–	–
125	125 Lexeo Therapeutics LXEO $216M	–	–	–	–